Ethicon Endo-Surgery Picks Up Obesity Neurostim Patents From Cyberonics
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson subsidiary Ethicon Endo-Surgery expanded its obesity treatment portfolio Dec. 18, gaining exclusive rights to neurostimulation patents from Cyberonics